Alzamend Neuro Inc (NQ: ALZN )
0.7200 UNCHANGED Streaming Delayed Price Updated: 3:57 PM EDT, Jun 8, 2023 Add to My Watchlist
Press Releases about Alzamend Neuro Inc
Alzamend Neuro Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
September 22, 2022
Alzamend Neuro to Present at Sequire Biotechnology Conference
January 26, 2023
Alzamend Neuro Partners With the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for ALZN002 Phase I/IIA Immunotherapy Vaccine Clinical Trial to Treat Mild to Moderate Dementia of the Alzheimer’s Type
December 28, 2022
Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
December 15, 2021
Palm Beach, FL – December 15, 2021 – FinancialNewsMedia.com News Commentary – Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs), however, it can also...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following